MA27539A1 - Nouvelle combinaison synergique contenant du roflumilast et du formoterol - Google Patents

Nouvelle combinaison synergique contenant du roflumilast et du formoterol

Info

Publication number
MA27539A1
MA27539A1 MA28343A MA28343A MA27539A1 MA 27539 A1 MA27539 A1 MA 27539A1 MA 28343 A MA28343 A MA 28343A MA 28343 A MA28343 A MA 28343A MA 27539 A1 MA27539 A1 MA 27539A1
Authority
MA
Morocco
Prior art keywords
formoterol
synergistic combination
combination containing
new synergistic
containing roflumilast
Prior art date
Application number
MA28343A
Other languages
English (en)
Inventor
Rolf Beume
Daniela Bundschuh
Norbert Kolassa
Degenhard Marx
Christian Weimar
Original Assignee
Altana Pharma Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Altana Pharma Ag filed Critical Altana Pharma Ag
Publication of MA27539A1 publication Critical patent/MA27539A1/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Abstract

La présente invention concerne l'administration combinée de roflumilast et de formotérol pour traiter des troubles des voies respiratoires.
MA28343A 2002-11-27 2005-06-16 Nouvelle combinaison synergique contenant du roflumilast et du formoterol MA27539A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP02026505 2002-11-27

Publications (1)

Publication Number Publication Date
MA27539A1 true MA27539A1 (fr) 2005-09-01

Family

ID=32338002

Family Applications (1)

Application Number Title Priority Date Filing Date
MA28343A MA27539A1 (fr) 2002-11-27 2005-06-16 Nouvelle combinaison synergique contenant du roflumilast et du formoterol

Country Status (32)

Country Link
US (1) US20060142308A1 (fr)
EP (1) EP1567139B1 (fr)
JP (1) JP2006508994A (fr)
KR (1) KR101071798B1 (fr)
CN (1) CN100346777C (fr)
AT (1) ATE399543T1 (fr)
AU (1) AU2003292120B2 (fr)
BR (1) BR0316451A (fr)
CA (1) CA2506962C (fr)
CO (1) CO5690570A2 (fr)
CY (1) CY1110369T1 (fr)
DE (1) DE60321953D1 (fr)
DK (1) DK1567139T3 (fr)
EA (1) EA009935B1 (fr)
ES (1) ES2309357T3 (fr)
HK (1) HK1081861A1 (fr)
HR (1) HRP20050579B1 (fr)
IL (1) IL168308A (fr)
IS (1) IS2575B (fr)
MA (1) MA27539A1 (fr)
ME (1) ME00489B (fr)
MX (1) MXPA05005437A (fr)
NO (1) NO334247B1 (fr)
NZ (1) NZ540659A (fr)
PL (1) PL216752B1 (fr)
PT (1) PT1567139E (fr)
RS (1) RS51081B (fr)
SI (1) SI1567139T1 (fr)
TN (1) TNSN05131A1 (fr)
UA (1) UA83018C2 (fr)
WO (1) WO2004047829A1 (fr)
ZA (1) ZA200503308B (fr)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MY140561A (en) * 2002-02-20 2009-12-31 Nycomed Gmbh Dosage form containing pde 4 inhibitor as active ingredient
RS52908B (en) 2003-03-10 2014-02-28 Takeda Gmbh NEW PROCEDURE FOR OBTAINING ROFLUMILAST
EP1861074B1 (fr) * 2005-03-16 2013-04-24 Takeda GmbH Forme de dosage cachant le goût comprenant du roflumilaste
DE102005030733A1 (de) * 2005-07-01 2007-01-04 Boehringer Ingelheim Pharma Gmbh & Co. Kg Neue Arzneimittelkombinationen zur Behandlung von Atemwegserkrankungen enthaltend langwirksame Beta-2-Agonisten und wenigstens einen weiteren Wirkstoff
EP2359826B1 (fr) * 2006-07-05 2013-10-30 Takeda GmbH Combinaison d'un inhibiteur de la HMG-CoA reductase rosuvastatine avec un inhibiteur de la phosphodiesterase 4, tel que roflumilast, roflumilast-N-oxyde, pour le traitement de maladies pulmonaires inflammatoires
WO2013077830A1 (fr) * 2011-11-25 2013-05-30 Mahmut Bilgic Associations actives sur le plan synergique contenant du roflumilast et du carmotérol
US20130172303A1 (en) * 2012-01-03 2013-07-04 Forest Laboratories Holdings Ltd. Roflumilast compositions for the treatment of copd
KR102154104B1 (ko) * 2013-01-28 2020-09-09 인코젠 쎄라퓨틱스 프라이빗 리미티드 로플루밀라스트 n- 옥사이드의 흡입에 의한 자가면역, 호흡 및 염증성 장애의 치료방법
CN104800214A (zh) * 2014-01-27 2015-07-29 成都英诺新科技有限公司 一种罗氟司特吸入气雾剂复方及制备方法

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5795564A (en) * 1991-04-05 1998-08-18 Sepracor, Inc. Methods and compositions for treating pulmonary disorders using optically pure (R,R)-formoterol
ES2176252T3 (es) * 1993-07-02 2002-12-01 Altana Pharma Ag Benzamidas sustituidas con fluoro-alcoxi y su utilizacion como agentes inhibidores de fosfodiesterasas de nucleotidos ciclicos.
BR9807399B1 (pt) * 1997-02-17 2011-04-19 composição para o tratamento de sìndrome da angústia respiratória infantil (irds) ou sìndrome da angústia respiratória aguda (ards) compreendendo 3-(ciclopropilmetóxi)-n-(3,5-dicloro-4-piridinil)-4-(difl uorometóxi) benzamida e tensoativo do pulmão, e seu uso.
US6333354B1 (en) * 1997-02-28 2001-12-25 Byk Gulden Lomberg Chemische Fabrik Gmbh Synergistic combination of PDE inhibitors and adenylate cyclase agonists or guanyl cyclyse agonists
US6624181B1 (en) * 1997-02-28 2003-09-23 Altana Pharma Ag Synergistic combination
WO2000012078A1 (fr) * 1998-08-26 2000-03-09 Smithkline Beecham Corporation Compositions pour le traitement de maladies pulmonaires
US6303145B2 (en) * 1999-05-10 2001-10-16 Sepracor Inc. (S,R) formoterol methods and compositions
ATE320800T1 (de) * 1999-08-21 2006-04-15 Altana Pharma Ag Synergistische kombination von roflumilast und salmeterol
GB0103630D0 (en) * 2001-02-14 2001-03-28 Glaxo Group Ltd Chemical compounds
EP1370521B1 (fr) * 2001-03-22 2007-12-19 Glaxo Group Limited Derives formanilides utilises en tant qu'agonistes de l'adrenorecepteur beta2
CZ20032958A3 (en) * 2001-04-30 2004-03-17 Glaxo Group Limited Anti-inflammatory 17.beta.-carbothioate ester derivatives of androstane with a cyclic ester group in position 17.alpha

Also Published As

Publication number Publication date
CN100346777C (zh) 2007-11-07
EP1567139A1 (fr) 2005-08-31
PL216752B1 (pl) 2014-05-30
RS51081B (sr) 2010-10-31
UA83018C2 (uk) 2008-06-10
AU2003292120A1 (en) 2004-06-18
RS20050382A (en) 2007-08-03
WO2004047829A1 (fr) 2004-06-10
BR0316451A (pt) 2005-10-11
AU2003292120B2 (en) 2010-01-21
HRP20050579A2 (hr) 2006-04-30
NO334247B1 (no) 2014-01-20
IL168308A (en) 2010-12-30
ES2309357T3 (es) 2008-12-16
CN1713903A (zh) 2005-12-28
HK1081861A1 (en) 2006-05-26
SI1567139T1 (sl) 2008-12-31
MXPA05005437A (es) 2005-08-03
CA2506962C (fr) 2012-01-03
NZ540659A (en) 2007-05-31
PL377732A1 (pl) 2006-02-06
ATE399543T1 (de) 2008-07-15
CY1110369T1 (el) 2015-04-29
DE60321953D1 (de) 2008-08-14
CA2506962A1 (fr) 2004-06-10
PT1567139E (pt) 2008-10-01
JP2006508994A (ja) 2006-03-16
IS7898A (is) 2005-06-20
KR20050085104A (ko) 2005-08-29
US20060142308A1 (en) 2006-06-29
EP1567139B1 (fr) 2008-07-02
HRP20050579B1 (hr) 2014-01-31
EA200500774A1 (ru) 2005-12-29
TNSN05131A1 (en) 2007-05-14
WO2004047829A8 (fr) 2005-06-30
EA009935B1 (ru) 2008-04-28
NO20052999L (no) 2005-06-17
ZA200503308B (en) 2006-11-29
IS2575B (is) 2010-02-15
DK1567139T3 (da) 2008-11-03
KR101071798B1 (ko) 2011-10-11
CO5690570A2 (es) 2006-10-31
ME00489B (me) 2011-10-10

Similar Documents

Publication Publication Date Title
MA27539A1 (fr) Nouvelle combinaison synergique contenant du roflumilast et du formoterol
TNSN07063A1 (fr) Utilisations therapeutiques d'inhibiteurs de rtp801
ATE320800T1 (de) Synergistische kombination von roflumilast und salmeterol
MA27334A1 (fr) Utilisation d'inhibiteurs de l'ikb kinase dans le traitement de la douleur
NO20025601D0 (no) Arylmetylaminderivater for anvendelse som tryptaseinhibitorer
HK1087702A1 (en) Arylmethylamine derivatives for use as tryptase inhibitors
ATE318601T1 (de) Zusammensetzungen zur behandlung des schnupfens, welche ipratropium und xylometazolin enthalten
ATE219657T1 (de) Nasale lösungen
HUP0103781A2 (hu) Megismerési képesség javítására szolgáló gyógyszerkészítmények, melyek atipikus antipszihotikus szer és acetilkolinészteráz inhibitor kombinációját tartalmazzák
MXPA05009986A (es) Tratamiento de la enfermedad de alzheimer.
ATE311928T1 (de) (-)-pseudoephedrin als sympathomimetisches arzneimittel
HUP0301128A2 (hu) 5-Metil-2-(2'-kloro-6'-fluoranilino)-fenilecetsavat tartalmazó gyógyszerkészítmények ciklooxigenáz-2-vel kapcsolatos betegségek kezelésére és alkalmazásuk
BR9915123A (pt) Composição de uma substância farmaceuticamente ativa e dispensador
MXPA04002560A (es) Combinacion de un nsaid y un inhibidor pde-4.
MA28266A1 (fr) Utilisation de l'agomelatine pour l'obtention de medicaments destines au traitement des troubles bipolaires
GEP20053512B (en) S-Methyl-Dihydro-Ziprasidone for Treatment of Psychiatric and Ocular Disorders.
MD2875F1 (en) Remedy for nasal congestion treatment
DE60126504D1 (de) Verwendung von gegen candida wirksamen mitteln zur behandlung von störungen der oralen und intestinalen mucosa
TNSN01081A1 (fr) Compositions de s-methyl-dihydro-ziprasidone
MA27291A1 (fr) Acides phenoxyacetiques substitues